ICS OPPORTUNITIES LTD. 13D and 13G filings for Albireo Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-02 4:26 pm Purchase | 2023-02-21 | 13G | Albireo Pharma, Inc. ALBO | ICS OPPORTUNITIES LTD. | 999,363 4.800% | 999,363 (New Position) | Filing |